In this study, we want to find out if a new drug called Soquelitinib (also known as CPI-818) can be safely given to people. We are also checking to see if it can help treat a type of cancer called relapsed peripheral T-cell lymphoma (PTCL).
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Anne Beaven
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Blood Conditions
Cancer (Lymphoma)
24-1765
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
